We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Orion Group (ORN - Free Report) : This construction company, which provides services on and off the water primarily in the continental United States, Alaska, Canada and the Caribbean Basin, has seen the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Lam Research (LRCX - Free Report) : This company which, supplies wafer fabrication equipment and services to the semiconductor industry, has seen the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Globus Medical (GMED - Free Report) : This medical device company, that develops and commercializes healthcare solutions for patients with musculoskeletal disorders, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
MYR Group (MYRG - Free Report) : This leading specialty contractors, which serves the electrical infrastructure market throughout the United States and Canada who have the experience and expertise to complete electrical installations of any type and size, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 day.
Catalyst Pharmaceuticals (CPRX - Free Report) : This commercial-stage biopharmaceutical company which, is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has seen the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Image: Bigstock
New Strong Buy Stocks for March 4th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Orion Group (ORN - Free Report) : This construction company, which provides services on and off the water primarily in the continental United States, Alaska, Canada and the Caribbean Basin, has seen the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Orion Group Holdings, Inc. Price and Consensus
Orion Group Holdings, Inc. price-consensus-chart | Orion Group Holdings, Inc. Quote
Lam Research (LRCX - Free Report) : This company which, supplies wafer fabrication equipment and services to the semiconductor industry, has seen the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Lam Research Corporation Price and Consensus
Lam Research Corporation price-consensus-chart | Lam Research Corporation Quote
Globus Medical (GMED - Free Report) : This medical device company, that develops and commercializes healthcare solutions for patients with musculoskeletal disorders, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
Globus Medical, Inc. Price and Consensus
Globus Medical, Inc. price-consensus-chart | Globus Medical, Inc. Quote
MYR Group (MYRG - Free Report) : This leading specialty contractors, which serves the electrical infrastructure market throughout the United States and Canada who have the experience and expertise to complete electrical installations of any type and size, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 day.
MYR Group, Inc. Price and Consensus
MYR Group, Inc. price-consensus-chart | MYR Group, Inc. Quote
Catalyst Pharmaceuticals (CPRX - Free Report) : This commercial-stage biopharmaceutical company which, is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has seen the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.